Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phytoecdysteroids are plant-derived analogues of insect molting hormones, with 20-hydroxyecdysone being the most studied. Recent research has explored their potential in bone health, including osteoporosis. Preclinical studies, mostly in animals and in vitro, have shown that phytoecdysteroids can stimulate osteoblast activity (cells that build bone) and inhibit osteoclastogenesis (cells that break down bone). For example, several rodent studies demonstrated increased bone mineral density and improved bone microarchitecture following administration of phytoecdysteroids, particularly 20-hydroxyecdysone. Mechanistic investigations suggest these effects may be mediated through the activation of estrogen receptors, upregulation of bone formation markers, and suppression of inflammatory cytokines that promote bone resorption.

However, there are currently no high-quality human clinical trials evaluating the efficacy of phytoecdysteroids in the treatment or prevention of osteoporosis. Most evidence comes from laboratory and animal models, which, while promising, do not always translate directly to humans. Despite a plausible biological rationale and positive preclinical findings, the lack of robust clinical evidence limits the justification for their use in humans at this time. Thus, the scientific evidence supporting phytoecdysteroids for osteoporosis is preliminary and rated as low (2/5). Further research, particularly well-designed clinical trials, is needed before phytoecdysteroids can be recommended for the management of osteoporosis.

More about Phytoecdysteroid
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by Phytoecdysteroid

Products containing Phytoecdysteroid